Hangzhou Dac Biotechnology Co., Ltd.

This early-stage study tests a new drug called DXC014 in people with advanced solid tumors, including small cell lung cancer, melanoma, and prostate cancer. The main goal is to check safety and find the right dose. About 150 participants will take part in this first-in-human tria…

This early-stage study tests a new drug, DXC008, for safety and the right dose in people with prostate cancer or other solid tumors like Ewing sarcoma. About 110 adults who have not responded to standard treatments will take part. The goal is to see if the drug is safe and to get…